Search For

Predicting cardiovascular-kidney-metabolic multimorbidity in Chinese adults with overweight and obesity using machine learning: an internal evaluation

Estimation of liver fibrosis and cirrhosis risk using non-invasive biomarkers in people living with HIV and prediabetes in Tanzania

CagriSema: a novel dual-pathway approach to target obesity and its complications

MASH as a network disease: therapeutic modulation of interorgan immunometabolic architecture

The application of GLP-1 receptor agonists in obesity due to MC4R deficiency

Problems with FIB-4 as an initial screening tool for liver fibrosis in patients with type 2 diabetes

History of gestational diabetes mellitus or hypertensive disorders of pregnancy and risk of chronic kidney disease

Lipid-associated macrophages in metabolic dysfunction-associated steatotic liver disease: immune regulation of lipid burden

Incretin-based therapy for MASH: are two better than one?

Pharmacologic management of metabolic and alcohol-associated liver disease

Advanced glycation endproduct-RAGE signaling fosters diabetic cardiomyopathy by enhancing cuproptosis and mitochondrial injury

Mechanism-driven therapy for diabetic cardiovascular disease